Young platelet millionaires with essential thrombocythemia

Am J Hematol. 2021 Apr 1;96(4):E93-E95. doi: 10.1002/ajh.26114. Epub 2021 Feb 18.

Authors

Naseema Gangat¹, Natasha Szuber², Tabinda Jawaid¹, Curtis A Hanson³, Animesh Pardanani¹, Ayalew Tefferi¹

Affiliations

¹ Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
² Department of Hematology, Université de Montréal, Montréal, Quebec, Canada.
³ Division of Hematopathology, Department of Laboratory Medicine, Mayo Clinic, Rochester, Minnesota.

PMID: 33524176
DOI: 10.1002/ajh.26114

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Age Factors
Disease Progression
Embolism / epidemiology
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Leukemia, Myeloid / epidemiology
Male
Phenotype
Platelet Count*
Primary Myelofibrosis / epidemiology
Prognosis
Retrospective Studies
Risk Factors
Thrombocythemia, Essential / blood*
Thrombocythemia, Essential / drug therapy
Thrombocythemia, Essential / genetics
Thrombocythemia, Essential / mortality
Thrombophilia / etiology
Young Adult